000 | 00986 a2200277 4500 | ||
---|---|---|---|
005 | 20250514004208.0 | ||
264 | 0 | _c20011018 | |
008 | 200110s 0 0 eng d | ||
022 | _a1389-4501 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aQawi, I | |
245 | 0 | 0 |
_aNew developments in anti-platelet therapies: potential use of CD39/vascular ATP diphosphohydrolase in thrombotic disorders. _h[electronic resource] |
260 |
_bCurrent drug targets _cJun 2001 |
||
300 |
_a213-4 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 |
_aAdenosine Triphosphatases _xtherapeutic use |
650 | 0 | 4 |
_aAntigens, CD _xtherapeutic use |
650 | 0 | 4 |
_aApyrase _xtherapeutic use |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aThrombosis _xdrug therapy |
700 | 1 | _aRobson, S C | |
773 | 0 |
_tCurrent drug targets _gvol. 2 _gno. 2 _gp. 213-4 |
|
999 |
_c11397345 _d11397345 |